Economic Impact of and Treatment Options for Type 2 Diabetes
Strategies for Addressing the Cost of Nonadherence in Diabetes
Overview of the Cardiovascular Benefit With Diabetic Agents and Novel Combination Products for Type 2 Diabetes
Utilizing Advances in Diabetes and Targeting Medication Adherence to Enhance Clinical Outcomes and Manage Costs for Type 2 Diabetes Posttest
Participating Faculty